olmesartan

Olmesartan (RNH 6270) is an Angiotensin II Type I receptor antagonist. Olmesartan is the active form of the antihypertensive drug olmesartan medoxomil,and has antihypertensive activity.

Olmesartan Medoxomil (Benicar) is an angiotensin II type 1 receptor blocker that is used to manage hypertension.

Olmesartan ethyl ester (compound 11), an impurity of Olmesartan (RNH-6270), functions as an antagonist to the angiotensin II receptor (AT1R), primarily utilized in studies related to high blood pressure [1].

Olmesartan impurity, a compound related to Olmesartan, is an angiotensin II receptor (AT1R) antagonist utilized in the study of high blood pressure. Olmesartan (RNH-6270) is the parent compound with similar properties and functions as an AT1R antagonist.

Olmesartan medoxomil impurity C is an impurity of Olmesartan medoxomil, a potent and selective angiotensin (AT1 receptor) inhibitor with an IC50 of 66.2 μM.

Trityl olmesartan medoxomil impurity III is a specific impurity present in trityl olmesartan medoxomil, an intermediate used in the synthesis of Olmesartan medoxomil [1].

Olmesartan-d6 Acid is a deuterated compound of Olmesartan Acid. Olmesartan Acid has a CAS number of 144689-24-7. Olmesartan is an Angiotensin II Type I receptor antagonist. Olmesartan is the active form of the antihypertensive drug olmesartan medoxomil,and has antihypertensive activity.

Olmesartan methyl ester is an intermediate in the synthesis of Olmesartan medoxomil, a potent and selective angiotensin AT1 receptor antagonist.

Olmesartan D4 is the deuterium labeled Olmesartan. Olmesartan is an antagonist of angiotensin II receptor (AT1R) used to treat high blood pressure.

Dehydro Olmesartan, deriving from Olmesartan, acts as an angiotensin II receptor (AT1R) antagonist and exhibits potential for the study of high blood pressure [1][2].

Olmesartan lactone impurity is a cyclic ester impurity derived from Olmesartan, an angiotensin II receptor (AT1R) antagonist with potential applications in the study of high blood pressure.

Tritylolmesartan medoxomil is an intermediate in the synthesis of olmesartan medoxomil , a prodrug form of the angiotensin II receptor 1 (AT1) antagonist olmesartan .1 1.Hanumantha Rao, B., Subramanyeswara Rao, I.V., Ravi Kanth, V., et al.A competent and commercially viable process for the synthesis of the anti-hypertensive drug olmesartan medoxomilSci. Pharm.83(3)465-478(2015)